Acadian Asset Management
GYRE icon

Acadian Asset Management’s Gyre Therapeutics GYRE Stock Holding History

Acadian Asset Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed – – 2186
2024
Q2 		$0 Hold
1
– – ﹤0.01% 1816
2024
Q1 		$0 Buy
+1
New +$18 ﹤0.01% 1648
2023
Q4 		– Sell
-4,253
Closed -$30K – 1720
2023
Q3 		$30K Sell
4,253
-5,349
-56% -$35.8K ﹤0.01% 1483
2023
Q2 		$50K Sell
9,602
-7,696
-44% -$27.6K ﹤0.01% 1532
2023
Q1 		$52K Buy
+17,298
New +$65.7K ﹤0.01% 1510
2022
Q3 		– Sell
-776
Closed -$10K – 1737
2022
Q2 		$10K Sell
776
-15,063
-95% -$100K ﹤0.01% 1642
2022
Q1 		$77K Sell
15,839
-15,148
-49% -$75.1K ﹤0.01% 1412
2021
Q4 		$211K Buy
+30,987
New +$530K ﹤0.01% 1223
2019
Q2 		– Sell
-7,861
Closed -$478K – 1905
2019
Q1 		$478K Sell
7,861
-7,010
-47% -$450K ﹤0.01% 1111
2018
Q4 		$880K Sell
14,871
-7,216
-33% -$532K ﹤0.01% 762
2018
Q3 		$1.79M Buy
22,087
+8,082
+58% +$640K 0.01% 591
2018
Q2 		$1.23M Buy
+14,005
New +$2.46M 0.01% 684

Other funds holding GYRE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AACP
Advantage Alpha Capital Partners San Francisco, California $332M AUM 12.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Acadian Asset Management's GYRE Position: Q3 2024 in Review

Acadian Asset Management sold out of Gyre Therapeutics (GYRE) in Q3 2024, closing a stake of 1 share.

Acadian Asset Management first reported a position in GYRE in Q2 2018 and held it in 12 quarters. The position peaked at $1.79M in Q3 2018. 37 funds tracked by Wall St. Rank hold GYRE as of Q3 2024.

  • Acadian Asset Management reported no remaining Gyre Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 1 Gyre Therapeutics share in Q3 2024.
  • Acadian Asset Management first reported a position in Gyre Therapeutics in Q2 2018 and held it in 12 quarters.
  • Acadian Asset Management's Gyre Therapeutics position peaked at $1.79M in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.